The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I and Pharmacokinetic Study of L377202, a Novel Peptide Doxorubicin Conjugate, in Patients with Advanced Prostate Cancer.
 
Steven Brad Maron
Travel, Accommodations, Expenses - Aduro Biotech
 
Smita Suhas Joshi
No Relationships to Disclose
 
S Lomnicki
No Relationships to Disclose
 
Tomasz Oliwa
No Relationships to Disclose
 
Stacie Landron
No Relationships to Disclose
 
Julie Johnson
No Relationships to Disclose
 
Lesli Ann Kiedrowski
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
Consulting or Advisory Role - McKinsey & Company
 
Rebecca J Nagy
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Richard B. Lanman
Employment - Guardant Health; Veracyte
Leadership - Guardant Health
Stock and Other Ownership Interests - Guardant Health; Veracyte
Research Funding - Guardant Health
 
Yelena Yuriy Janjigian
Consulting or Advisory Role - Lilly; Pfizer
Research Funding - Amgen; Bayer; Boehringer Ingelheim; Genentech; Lilly; Roche
 
Kaitlyn J. Kelly
No Relationships to Disclose
 
Seung Tae Kim
No Relationships to Disclose
 
Jeeyun Lee
No Relationships to Disclose
 
Daniel V.T. Catenacci
Honoraria - Amgen; Bristol-Myers Squibb; Five Prime Therapeutics; Foundation Medicine; Genentech/Roche; Genmab; Gritstone Bio; Guardant Health; Lilly; Merck; NantWorks; OncoPlex Diagnostics; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Genentech/Roche; OncoPlex Diagnostics
Speakers' Bureau - Foundation Medicine; Genentech/Roche; Guardant Health; Lilly; NantWorks
Research Funding - Genentech; OncoPlex Diagnostics